DFDA

Bronchodilators (e.g., LAMA/LABA)

Treatment for Coal Workers Pneumoconiosis

Typical Dosage: Varies by drug (e.g., Tiotropium 18mcg daily)

Effectiveness
65%
Safety Score
60%
Clinical Trials
400
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
Varies by drug (e.g., Tiotropium 18mcg daily)
Time to Effect
Minutes to weeks depending on agent
Treatment Duration
Lifetime (if symptoms persist)
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$400
Side Effect Mgmt:$50
Total Annual:$650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$3,250/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$1,083
Bronchodilators (e.g., LAMA/LABA) Outcomes

for Coal Workers Pneumoconiosis

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+60%
Common Side Effects
Dry mouth
+10%
Headache
+7%
Tremor
+5%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov